B/BE/21/BVW3 - Fiche d'information destinée au public (préparée par le notifiant)

File: 
PDF icon bbe21bvw3_pub_fr.pdf
Trial reference: 
Phase I/II study to evaluate the safety and effects on Progranulin levels of PR006 in patients with Fronto-Temporal Dementia with Progranulin mutations (FTD-GRN).
Doc type: 
Information for the public